Fox Run Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-6,043
Closed -$387K 798
2018
Q4
$387K Sell
6,043
-2,722
-31% -$201K 0.21% 188
2018
Q3
$784K Buy
8,765
+4,101
+88% +$362K 0.34% 36
2018
Q2
$370K Buy
+4,664
New +$387K 0.12% 355
2018
Q1
Sell
-6,295
Closed -$657K 1064
2017
Q4
$657K Buy
6,295
+395
+7% +$44.6K 0.19% 183
2017
Q3
$860K Buy
+5,900
New +$804K 0.24% 102
2017
Q1
Sell
-3,300
Closed -$382K 858
2016
Q4
$382K Buy
+3,300
New +$368K 0.2% 216
2016
Q3
Sell
-4,300
Closed -$424K 834
2016
Q2
$424K Sell
4,300
-6,500
-60% -$672K 0.21% 171
2016
Q1
$1.08M Buy
+10,800
New +$1.11M 0.72% 6

Other funds holding CELG

Fox Run Management's CELG Position: Q1 2019 in Review

Fox Run Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 6,043 shares — an estimated $387K sold.

Fox Run Management first reported a position in CELG in Q1 2016 and held it in 8 quarters. The position peaked at $1.08M in Q1 2016. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Fox Run Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Fox Run Management sold 6,043 Celgene Corp shares in Q1 2019, an estimated $387K.
  • Fox Run Management first reported a position in Celgene Corp in Q1 2016 and held it in 8 quarters.
  • Fox Run Management's Celgene Corp position peaked at $1.08M in Q1 2016.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Fox Run Management's 13F filing for Q1 2019, filed 17 Oct 2019.